The blood thinner medication known as Pradaxa is currently under scrutiny, as the drug has been known to cause severe bleeding, sometimes resulting in death. Pradaxa is a drug manufactured…
Read More
Court convened in the Pradaxa Multi-District Litigation (MDL) known as In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation) MDL No. 2385 for a Status Conference on January 14, 2013. The…
Read More
In a federal Illinois court, Boehringer Ingelheim has been fined $1 million for neglecting to retain documents pertinent to a multidistrict litigation (MDL). It is unclear if the German pharmaceutical…
Read More
The Pradaxa multi-district litigation (MDL) met in early February for a status conference to discuss recent progress made in the discovery and deposition processes. According to Seth A. Katz, one…
Read More
Published September 27, 2012 by LawsuitInformation.org Pradaxa is an anticoagulant drug intended to reduce the risk of stroke in patient's suffering from non-valvular atrial fibrillation. Manufactured by Boehringer Ingelheim, Pradaxa…
Read More
Carey Danis & Lowe Pradaxa lawyers are currently following the Pradaxa multi-district litigation (MDL) in Illinois. The Pradaxa MDL is In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL no.…
Read More
On December 19, the U.S. Food and Drug Administration (FDA) released a safety announcement regarding the anticoagulant medicine known as Pradaxa. Pradaxa, known generically as dabigatran etexilate mesylate, is manufactured…
Read More
Though the drug manufacturer denies Pradaxa as a defective drug, the surmounting Pradaxa bleeding deaths, injuries, and lawsuits prove otherwise. Pradaxa was introduced onto the U.S. drug market in October…
Read More
In early November, the U.S. Food and Drug Administration (FDA) released a statement about its recent research into the incidence of excessive bleeding and Pradaxa use in patients with atrial…
Read More